BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+0.68%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$10.2B
AUM Growth
+$10.2B
Cap. Flow
-$627M
Cap. Flow %
-6.14%
Top 10 Hldgs %
83.92%
Holding
141
New
7
Increased
13
Reduced
18
Closed
7

Top Buys

1
SGEN
Seagen Inc. Common Stock
SGEN
$85M
2
AKAO
Achaogen, Inc.
AKAO
$58.4M
3
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$53.4M
4
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$30.5M
5
AVXS
AveXis, Inc. Common Stock
AVXS
$15M

Top Sells

1
ABBV icon
AbbVie
ABBV
$793M
2
EXEL icon
Exelixis
EXEL
$28.7M
3
TGTX icon
TG Therapeutics
TGTX
$15.5M
4
ARWR icon
Arrowhead Research
ARWR
$13.6M
5
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$13.3M

Sector Composition

1 Healthcare 81.65%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
$2.41B 23.65% 45,711,856 +1,611,562 +4% +$85M
INCY icon
2
Incyte
INCY
$16.5B
$2.36B 23.1% 23,499,087 +189 +0% +$19K
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$801M 7.85% 6,543,295 – –
ACAD icon
4
Acadia Pharmaceuticals
ACAD
$4.38B
$745M 7.3% 25,819,768 – –
GHDX
5
DELISTED
Genomic Health, Inc.
GHDX
$405M 3.97% 13,770,302 – –
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.2B
$398M 3.9% 4,806,483 – –
DBVT
7
DBV Technologies
DBVT
$264M
$194M 1.9% 5,509,560 – –
NGNE icon
8
Neurogene
NGNE
$264M
$174M 1.71% 10,536,092 – –
ONC
9
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$112M 1.09% 3,673,175 +1,760,495 +92% +$53.4M
ABBV icon
10
AbbVie
ABBV
$372B
$106M 1.04% 1,685,994 -12,657,364 -88% -$793M
BCRX icon
11
BioCryst Pharmaceuticals
BCRX
$1.74B
$69.4M 0.68% 10,963,944 – –
AMRN
12
Amarin Corp
AMRN
$311M
$68.3M 0.67% 22,169,509 +1,539,032 +7% +$4.74M
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$66.3M 0.65% 4,865,647 – –
ONCE
14
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$65.8M 0.64% 1,318,341 – –
ACOR
15
DELISTED
Acorda Therapeutics, Inc.
ACOR
$62.1M 0.61% 3,301,791 -359,291 -10% -$6.75M
AKAO
16
DELISTED
Achaogen, Inc.
AKAO
$59.7M 0.58% 4,582,382 +4,482,382 +4,482% +$58.4M
AAAP
17
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$58M 0.57% 2,167,137 +1,137,890 +111% +$30.5M
NVTA
18
DELISTED
Invitae Corporation
NVTA
$57.9M 0.57% 7,288,300 +733,333 +11% +$5.82M
CERS icon
19
Cerus
CERS
$251M
$56.8M 0.56% 13,053,275 – –
EXEL icon
20
Exelixis
EXEL
$10.1B
$44.8M 0.44% 3,003,569 -1,925,925 -39% -$28.7M
NBIX icon
21
Neurocrine Biosciences
NBIX
$13.8B
$34.7M 0.34% 895,422 – –
HRTX icon
22
Heron Therapeutics
HRTX
$207M
$31.2M 0.31% 2,383,569 -473,681 -17% -$6.21M
ARAV
23
DELISTED
Aravive, Inc. Common Stock
ARAV
$28.6M 0.28% 1,920,845 -213,402 -10% -$3.18M
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$27.4M 0.27% 2,466,702 – –
PGNX
25
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$27.2M 0.27% 3,150,808 -500,000 -14% -$4.32M
1
2 3 4 5